CSE: SWEL
AQSE: SWEL
FRA: 484
OTC: SCNNF

Backed by some of Europe's most
experienced hemp cultivators

The Stillcanna team has over 40 years of combined experience in agricultural chemistry and have become familiar with key factors in the hemp cultivation cycle. By understanding and optimizing the process, we can consistently supply high-quality, CBD-rich hemp biomass to our state-of-the-art extraction facilities and the global CBD market.

EU Integrated and Approved

Fully integrated and sanctioned to EU standards to capitalize on the increasing European demand for cannabinoid-based products.

Strategically Licensed

Fully licensed for cultivation, extraction, formulation sales and exports including a medicinal CBD license in Poland.

Proprietary Inputs

We own a proprietary, EU-registered high CBD content strain of hemp as well as a patented microelement fertilizer.

THE STILLCANNA CULTIVATION MARKET ADVANTAGE

  • Multi-generational agricultural expertise
  • Both organic and certified organic crops
  • Proprietary inputs and processes for consistent, high-yield cultivation.
  • One of only three companies within Europe to have its own proprietary and registered hemp seed.

Operational Timeline

2020

We own a proprietary, EU-registered high CBD content strain of hemp as well as a patented microelement fertilizer.

2020

We further plan to increase production in 2021 with a potential gross yield up to 50,000 kilos of CBD.

Estimated biomass: 1,00,000 kg

Estimated gross CBD yield: 50,000 kg *Should the biomass contain 5% CBD by volume.

Stay current with Sativa Wellness Group

Subscribe

We are committed to producing safe, compliant and effective products.

Twitter Linkedin Instagram
Our Brands
Who We Are
Code of Ethics
Advisors
  • The Blue Building, Stubbs Lane, Beckington, Somerset BA11 6TE
  • 609 Granville Street, Suite 2200, Vancouver, BC V7Y 1H2, Canada
  • 01373 486595
  • [email protected]

© 2020 Sativa Wellness Group Inc. All Rights Reserved.

CSE: SWEL
AQSE: SWEL
FRA: 484
OTC: SCNNF